Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Mobilization and Outcomes After Venous Closure

ClinicalTrials.gov ID: NCT07246902

Public ClinicalTrials.gov record NCT07246902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 5:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

MOVE - Mobilization and Outcomes After VEnous Closure - A Prospective Registry of Real-World Outcomes/Usage/Evidence for the MYNX CONTROL™ VENOUS Vascular Closure Device 6F-12F

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.

Study identification

NCT ID
NCT07246902
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Cordis US Corp.
Industry
Enrollment
339 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 24, 2025 (Actual)
Primary completion
Aug 26, 2026 (Actual)
Completion
Aug 26, 2026 (Actual)
Last update posted
Sep 18, 2026

2025 – 2026

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Cedars Sinai Medical Center Los Angeles California 90048 —
Stanford University School of Medicine Palo Alto California 94304 —
South Denver Cardiology Littleton Colorado 80210 —
AdventHealth Orlando Orlando Florida 32803 —
Glenbrook Hospital Glenview Illinois 60026 —
KC Heart and Rhythm Institute Overland Park Kansas 66211 —
Baptist Health Lexington Lexington Kentucky 40503 —
North Carolina Heart & Vascular Research, LLC Raleigh North Carolina 27607 —
Overlake Medical Center Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07246902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07246902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →